Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Times Interest Earned: 2011-2025

Historic Times Interest Earned for Adma Biologics (ADMA) over the last 10 years, with Sep 2025 value amounting to $30.45.

  • Adma Biologics' Times Interest Earned rose 168.84% to $30.45 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.97, marking a year-over-year increase of 200.12%. This contributed to the annual value of $9.98 for FY2024, which is 1054.31% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Times Interest Earned is $30.45, which was up 30.51% from $23.34 recorded in Q2 2025.
  • Adma Biologics' Times Interest Earned's 5-year high stood at $30.45 during Q3 2025, with a 5-year trough of -$4.80 in Q2 2021.
  • Over the past 3 years, Adma Biologics' median Times Interest Earned value was $10.36 (recorded in 2024), while the average stood at $10.52.
  • Data for Adma Biologics' Times Interest Earned shows a peak YoY soared of 13,899.75% (in 2024) over the last 5 years.
  • Over the past 5 years, Adma Biologics' Times Interest Earned (Quarterly) stood at -$3.98 in 2021, then surged by 73.45% to -$1.06 in 2022, then soared by 316.84% to $2.29 in 2023, then spiked by 481.25% to $13.31 in 2024, then soared by 168.84% to $30.45 in 2025.
  • Its Times Interest Earned stands at $30.45 for Q3 2025, versus $23.34 for Q2 2025 and $17.66 for Q1 2025.